Article Information
History
- September 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- John J. Cole1,
- Alison McColl1,
- Robin Shaw2,
- Mary-Ellen Lynall3,
- Philip J Cowen4,
- Peter de Boer5,†,
- Wayne C Drevets6,
- Neil Harrison7,
- Carmine Pariante8,
- Linda Pointon3,
- NIMA consortium,
- Carl Goodyear1,
- Edward Bullmore4 and
- Jonathan Cavanagh1,*
- 1Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK
- 2Cancer Research UK Beatson Institute, Glasgow, UK
- 3Department of Psychiatry, University of Cambridge, UK and Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK
- 4Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK
- 5Janssen Research and Development, Experimental Medicine-Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium
- 6Neuroscience Therapeutic Area, Janssen Research & Development, LLC, San Diego, CA, USA
- 7Cardiff University Brain Research Imaging Centre, Maindy Road, Cardiff, UK
- 8Stress, Psychiatry and Immunology Laboratory & Section of Perinatal Psychiatry, King’s College, University of London, London, UK
- ↵* Corresponding author: Professor Jonathan Cavanagh, Centre for Immunobiology, Sir Graeme Davies Building, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, E: Jonathan.Cavanagh{at}glasgow.ac.uk, P: 0141 330 7769
↵† We pay tribute to our Janssen colleague, the late Dr Peter de Boer. Peter was a man of great knowledge, integrity, kindness and humour. And we were lucky enough to have him at the heart of the NIMA consortium from the outset. He will be sorely missed.